Chemed Co. (NYSE:CHE) Shares Acquired by Aptus Capital Advisors LLC

Aptus Capital Advisors LLC increased its stake in shares of Chemed Co. (NYSE:CHE - Free Report) by 22.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 40,695 shares of the company's stock after acquiring an additional 7,327 shares during the period. Aptus Capital Advisors LLC owned about 0.27% of Chemed worth $21,561,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. UMB Bank n.a. increased its stake in Chemed by 300.0% during the 4th quarter. UMB Bank n.a. now owns 52 shares of the company's stock worth $28,000 after buying an additional 39 shares in the last quarter. Atala Financial Inc acquired a new stake in Chemed during the fourth quarter worth about $29,000. CBIZ Investment Advisory Services LLC increased its holdings in shares of Chemed by 64.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock worth $30,000 after buying an additional 22 shares during the last quarter. Trust Co. of Vermont purchased a new stake in Chemed in the fourth quarter valued at $34,000. Finally, Tortoise Investment Management LLC lifted its position in Chemed by 77.3% in the fourth quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock valued at $41,000 after buying an additional 34 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company's stock.

Chemed Trading Down 0.0 %

Shares of Chemed stock traded down $0.07 on Tuesday, hitting $576.00. The stock had a trading volume of 151,478 shares, compared to its average volume of 100,103. The company's 50 day moving average price is $590.41 and its 200 day moving average price is $565.56. The stock has a market cap of $8.43 billion, a price-to-earnings ratio of 29.11, a P/E/G ratio of 2.15 and a beta of 0.59. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $623.61.

Chemed (NYSE:CHE - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.59 by $0.04. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The company had revenue of $646.94 million for the quarter, compared to the consensus estimate of $641.78 million. During the same period last year, the firm posted $5.20 EPS. Chemed's revenue for the quarter was up 9.8% on a year-over-year basis. Analysts predict that Chemed Co. will post 21.43 EPS for the current fiscal year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 0.35%. The ex-dividend date was Monday, February 24th. Chemed's payout ratio is 9.74%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. Royal Bank of Canada boosted their price objective on Chemed from $667.00 to $674.00 and gave the company an "outperform" rating in a report on Monday, April 28th. StockNews.com upgraded shares of Chemed from a "hold" rating to a "buy" rating in a report on Friday, March 7th.

Insider Transactions at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm's stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total value of $1,187,340.00. Following the completion of the sale, the chief executive officer now owns 102,679 shares of the company's stock, valued at approximately $60,957,441.93. This trade represents a 1.91 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders have sold a total of 4,500 shares of company stock worth $2,667,345 over the last ninety days. 3.29% of the stock is currently owned by company insiders.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.